Selectivity index, ratio of TC50 for human HuH7 cells to IC50 for Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of HBsAg secretion
Selectivity index, ratio of TC50 for human HuH7 cells to IC50 for Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of HBeAg secretion
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of viral DNA replication by RT-PCR method
Selectivity index, ratio of TC50 for human HuH7 cells to IC50 for Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of viral DNA replication
Cytotoxicity against human HuH7 cells infected with Hepatitis B virus subtype adw2 assessed as reduction in cell viability at >80 ug/ml after 3 days by MTS assay
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as inhibition of viral DNA replication after 3 days by RT-PCR method
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in major S/preS RNA level at 2.5 to 10 ug/ml after 2 days by northern blot method
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in precore/pregenomic RNA level at 2.5 to 10 ug/ml after 2 days by northern blot method
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in SHBs level at 2.5 to 10 ug/ml after 2 days by immunoblot method
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in HBcAg level at 2.5 ug/ml after 2 days by immunoblot method relative to control
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in HBcAg level at 5 ug/ml after 2 days by immunoblot method relative to control
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in HBcAg level at 10 ug/ml after 2 days by immunoblot method relative to control
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as effect on HBx level at 2.5 ug/ml after 2 days by immunoblot method relative to control
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in HBx level at 5 ug/ml after 2 days by immunoblot method relative to control
Antiviral activity against Hepatitis B virus subtype adw2 infected in human HuH7 cells assessed as reduction in HBx level at 10 ug/ml after 2 days by immunoblot method relative to control